October 3rd 2022
This week's edition of the Mainstream Patient features stories about recommended acne solutions from dermatologists, Latinx-owned beauty brands, the latest skin care trend of "skin energy," and more.
September 15th 2022
Burst CME: Improving Outcomes for Your Patient with Vitiligo
View More
Burst CME: Improving Outcomes for Your Patient with Vitiligo
View More
Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication
View More
Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes
View More
Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication
View More
22nd Annual International Congress on the Future of Breast Cancer® East
View More
22nd Annual International Congress on the Future of Breast Cancer® East
View More
4th Annual International Congress on the Future of Women’s Health™
07/22/2023
View More
22nd Annual International Congress on the Future of Breast Cancer® West
View More
22nd Annual International Congress on the Future of Breast Cancer® West
View More
An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management
View More
An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management
View More
6th Annual Advanced Practice Collaborative
09/08/2023-09/09/2023
View More
Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments
View More
Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments
View More
Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team
View More
Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team
View More
Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
10/21/2023
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
10/21/2023
View More
Best Practice in the Multidisciplinary Care of the Patient with HS
View More
Addressing Challenges in the Management of HS in Special Populations
View More
Best Practice in the Multidisciplinary Care of the Patient with HS
View More
Addressing Challenges in the Management of HS in Special Populations
View More
Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer
View More
Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Topical Anesthetics in Cryotherapy:For More Comfortable, Satisfied Patients
July 15th 2004Cryotherapy is commonly performed in dermatology to treat numerous benign and premalignant skin lesions and some selected superficial skin cancers. The pain associated with this procedure occurs in two phases, immediately at onset and as the treated site thaws. The posttreatment thaw pain is the most intense and may inhibit patients from undergoing retreatment, should it become necessary. Application of a topical anesthetic, such as L.M.X.4?, after a lesion has thawed relieves the pain associated with cryotherapy.
Response rates high with imiquimod for multiple basal cell
May 1st 2004Washington D.C. -- Imiquimod 5 percent cream produces histologic response rates in excess of 70 percent in the treatment of multiple superficial basal cell carcinomas, according to study data presented at the 62nd annual meeting of the American Academy of Dermatology.
Hair loss in elderly may pack a potent psychological punch; evaluate carefully
May 1st 2004Washington - While hair loss may become more acceptable with increasing age, for some older people it is psychologically devastating and adds to the string of losses they may encounter, said Janet L. Roberts, M.D., at the annual meeting of the American Academy of Dermatology.
Melanoma unravels over the years
February 1st 2004National report - Harley A. Haynes, M.D., remembers a lecture he heard while a student at Harvard Medical School in the early 1960s. His professor showed a series of slides of melanoma and the basic message of his talk that day was: Sometimes, people get melanoma and then, they die.
Estrogen Effective Wound Healer
September 1st 2003San Francisco - Results of animal studies and limited clinical research indicate that estrogen can have a positive effect on wound healing, and findings from a case-cohort investigation provide preliminary evidence that oral estrogen in the form of hormone replacement therapy (HRT) might protect against the development of pressure ulcers and venous ulcers in an ambulatory population. However, a role of estrogen for treating those lesions remains to be defined, said David J. Margolis, M.D.